Descriptor English: | Clofarabine | ||||||
Descriptor Spanish: |
Clofarabina
| ||||||
Descriptor Portuguese: | Clofarabina | ||||||
Descriptor French: | Clofarabine | ||||||
Entry term(s): |
2 Chloro 2' arabino fluoro 2' deoxyadenosine 2 Chloro 2' fluoroarabino 2' deoxyadenosine 2-Chloro-2'-arabino-fluoro-2'-deoxyadenosine 2-Chloro-2'-fluoroarabino-2'-deoxyadenosine 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arbinofuranosyl)adenine 2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine 9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)- Cl-F-ara-A Clofarex Clolar Evoltra |
||||||
Tree number(s): |
D03.633.100.759.646.138.309 D13.570.065.195 D13.695.667.138.309 D13.695.827.068.309 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077866 | ||||||
Scope note: | An adenine arabinonucleoside derivative that acts as an antineoplastic antimetabolite. It is used in the treatment of ACUTE LYMPHOID LEUKEMIA in pediatric patients who have relapsed. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antimetabolites, Antineoplastic |
||||||
Registry Number: | 762RDY0Y2H | ||||||
CAS Type 1 Name: | 9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)- | ||||||
Public MeSH Note: | 2019; CLOFARABINE was indexed under ADENINE NUCLEOTIDES and ARABINONUCLEOSIDES 1991-2018 |
||||||
History Note: | 2019 (1991) |
||||||
DeCS ID: | 57769 | ||||||
Unique ID: | D000077866 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2019/04/29 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Clofarabine
- Preferred
Clolar
- Narrower
Evoltra
- Narrower
Clofarex
- Narrower
Concept UI |
M0186928 |
Scope note | An adenine arabinonucleoside derivative that acts as an antineoplastic antimetabolite. It is used in the treatment of ACUTE LYMPHOID LEUKEMIA in pediatric patients who have relapsed. |
Preferred term | Clofarabine |
Entry term(s) |
2 Chloro 2' arabino fluoro 2' deoxyadenosine 2 Chloro 2' fluoroarabino 2' deoxyadenosine 2-Chloro-2'-arabino-fluoro-2'-deoxyadenosine 2-Chloro-2'-fluoroarabino-2'-deoxyadenosine 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arbinofuranosyl)adenine 2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine 9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)- Cl-F-ara-A |
Concept UI |
M0478771 |
Preferred term | Clolar |
Concept UI |
M0498461 |
Preferred term | Evoltra |
Concept UI |
M0446643 |
Preferred term | Clofarex |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey